Baseline Characteristics
All patients (N= 114) (+) Developed AF (N= 46) (-) Developed AF (N= 68) (-) Developed AF (N= 68)
p value
BSA 2.07 + 0.2 2.1 + 0.3 2.1 + 0.2 2.1 + 0.2 0.9
BMI 29.9 + 8.0 30 + 8.9 29 + 7.5 29 + 7.5 0.7
Age (yrs) 67.5 + 10.5 68.9 + 11.8 66.5 + 9.5 66.5 + 9.5 0.1
Male Gender (%)
103 (90%)
42(91%)
61(90%) 61(90%)
1.0
DM (%) 21 (18.4%) 7(15%) 14(21%) 14(21%) 0.6
HTN (%) 68 (59.6%) 28(61%) 40 (59%) 40 (59%) 0.9
CAD (%) 23 (20.1%) 13(28%) 10(15%) 10(15%) 0.1
CVA/TIA (%) 9(7.9%) 3(7%) 6(9%) 6(9%) 0.7
CHF (%) 10 (8.8%) 6(13%) 4(6%) 4(6%) 0.2
OSA (%) 21 (18.4%) 10 (22%) 11 (16%) 11 (16%) 0.5
COPD (%) 18 (15.8%) 7 (15%) 11 (16%) 11 (16%) 1.0
NYHA Class (%) 0.3
I 31 (27%) 12 (26%) 12 (26%) 19 (28%)
II 30 (26%) 12 (26%) 12 (26%) 18 (26%)
III 7 (6%) 5 (11%) 5 (11%) 2 (3%)
CHADS-VASc ≥ 2 (%) 71 (62.3%) 28 (61%) 28 (61%) 43(63%) 1.00
HATCH Score 1.3 + 1.2 1.4 + 1.2 1.4 + 1.2 1.2 + 1.2 0.3
HATCH Score>=2 (%) 42 (36.8%) 22 (48%) 20(30%) 20(30%) 0.05
Days in Atrial Flutter (days) 88.1 + 186 113.3 + 255 70.6 + 116 70.6 + 116 0.9
Medications Medications Medications Medications Medications Medications
Beta Blockers (%) 59 (51.8 %) 29 (63%) 30 (44%) 30 (44%) 0.06
CCB (%) 29 (25.4%) 10 (22%) 19 (28%) 19 (28%) 0.5
ACEI/ARB/ARNI (%) 37 (32.5%) 13 (28%) 24(35%) 24(35%) 0.5
Anticoagulation (%) 72 (63.2%) 27 (59%) 45 (66%) 45 (66%) 0.4